Drug profile · INN
edaravone
RADICAVA
edaravone (RADICAVA) is a unknown. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — edaravone
- US status
- approved
- Class
- Nervous system (N07)
- Route
- ORAL
- Patents
- 0
- Programs
- 5
- Data quality
- 0.84
Quick answer
edaravone (RADICAVA) is a unknown. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Unknown
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | application withdrawn | — |
| TGA | approved | — |
| PMDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is edaravone?
edaravone (RADICAVA) is a unknown. Associated with Lacuna Pharma Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for edaravone?
RADICAVA is a marketed brand name for edaravone. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of edaravone?
edaravone has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.